Akoustis Technologies Inc (AKTS) Cotización

AKTS, was $4.58 in 2023.

AKTS......................https://stockcharts.com/h-sc/ui?s=AKTS&p=W&b=5&g=0&id=p86431144783

You read it correctly. Thanks for the reprint. For some reason. The words were cutting off so I coukd t see the RS numbers. U was only getting half the news. When I click on it. They will chose one if the 2 RS to ratify. 

And the way I read it is that the R/S will not be done away with but one of the ratios will be selected somewhere between 1-50 and 1-250 and all other ratios will be abandoned....but I could be reading it wrong.

3. to approve amendments to the Company’s certificate of incorporation, as amended (the “Certificate of Incorporation” or “Charter”), effecting reverse stock splits of the Company’s common stock at ratios between 1-for-50 and 1-for-250 inclusive, one of which amendments (and therefore one of which reverse stock split ratios) will be chosen by the Board of Directors in its sole discretion on or prior to the one year anniversary of the date of the Annual Meeting (the “Reverse Stock Split”), and the rest of which amendments (and therefore the rest of the reverse stock split ratios) will be abandoned;

You may of not scrolled down enough.

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON NOVEMBER 14, 2024 AT 10:00 A.M.

The 2024 Annual Meeting of Stockholders of Akoustis Technologies, Inc. (the “Company”) will be held on Thursday, November 14, 2024 at 10:00 a.m., local time, and any adjournments or postponements thereof (the “Annual Meeting”).The annual meeting will be held by means of remote communications, conducted via live webcast accessible at https://www.virtualshareholdermeeting.com/AKTS2024 for the following purposes:

1. to elect five directors of the Company to serve one-year terms expiring at the 2025 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier resignation or removal;

2. to approve, on a non-binding, advisory basis, the compensation paid to our named executive officers;

3. to approve amendments to the Company’s certificate of incorporation, as amended (the “Certificate of Incorporation” or “Charter”), effecting reverse stock splits of the Company’s common stock at ratios between 1-for-50 and 1-for-250 inclusive, one of which amendments (and therefore one of which reverse stock split ratios) will be chosen by the Board of Directors in its sole discretion on or prior to the one year anniversary of the date of the Annual Meeting (the “Reverse Stock Split”), and the rest of which amendments (and therefore the rest of the reverse stock split ratios) will be abandoned;

4. to ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2025; and

5. to transact such other business, if any, as may properly come before the Annual Meeting.

The Board of Directors is not aware of any other business to come before the Annual Meeting.

We have fixed September 24, 2024 as the record date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting. Only holders of record of the Company’s common stock at the close of business on that date will be entitled to notice of and to vote at the Annual Meeting and any adjournments thereof.

You are cordially invited to attend the Annual Meeting. Whether or not you plan to attend the Annual Meeting, your vote is important, and we encourage you to review these proxy materials and submit your voting instructions in advance of the Annual Meeting by Internet, telephone, or mail, as described on the enclosed proxy card. On or about [__], 2024, we will mail to stockholders as of the record date a notice with instructions on how to access our annual meeting materials and submit your voting instructions via the internet, by mail or telephone.

The Board of Directors recommends that stockholders vote “FOR” each of the director nominees, “FOR” the approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers, “FOR” the approval of the amendment to the Certificate of Incorporation to effect the Reverse Stock Split, and “FOR” the ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2025.

You may revoke your proxy at any time prior to or at the Annual Meeting (prior to the vote at the Annual Meeting) by written notice to the Company, by executing a proxy bearing a later date, or by attending the Annual Meeting and voting online.

Is this proxy vote to amend and do away with the RS.
I cant really see it with this new updated version of investorshub. 
It kind if cut off

Some one let me know please. I'm trying to decide if it's a good buy or leave it alone until the split

LOL...Now what I want to see is a release news the appeal has been filed and any delisting concern is suspended.
I want to see another purchase order of say...a half billion dollars...perhaps from the military would be nice.

AKTS..................................https://stockcharts.com/h-sc/ui?s=AKTS&p=W&b=5&g=0&id=p86431144783

I want to see another purchase order of say...a half billion dollars...perhaps from the military would be nice.

Volume in, pressure building up !

volume picking up

.1050 is a knockin.

Agree, getting thin on the way up !

.1050 break will take it to .12 quickly is what I am thinking

Almost that time, let’s GOOO

Coming off the 52WL, looks like a bottom to me, interesting !

Tail end of the forming W will go nuts

$AKTS The chart looks poised for a major breakout of .12 cents.

Still holding and ready.

Hopefully today it will breakout .10 and .12 gearing up to .20 and .30 BULLISH $$$

When is trial April 2025 ?

$AKTS I find it interesting that Akoustis has filed its patent infringement suit against Qorvo in the U.S. District Court for the Eastern District of Texas.
Last updated: Aug. 16, 2024, 3:23 p.m. (2:23-cv-00180)
https://www.courtlistener.com/docket/67232852/akoustis-technologies-inc-v-qorvo-inc/

Record orders and priced for Bankruptcy

I see...thanks pb...that is what I was wanting to know....what all is involved in deciding an appeal.

I don't have specific details about the appeals in the Akoustis and Qorvo case. However, generally, appeals in such cases involve reviewing the previous court’s decision, addressing any legal errors, and possibly re-evaluating damages or other aspects of the case.

$AKTS .095 Hod :)))) Akoustis ($AKTS) has contracts with the U.S. Department of Defense. They have been awarded multiple contracts from the Defense Advanced Research Projects Agency (DARPA) to advance their XBAW® technology12. These contracts include multi-year, multi-million dollar programs aimed at developing new materials and device manufacturing methods for both commercial and defense applications.

#243 for you. My VCIG just popped to .2579 and AKTS just hit .089 both stocks are super bargain discount $$$

Now that!... would be unlimited!...hell they might need a whole individual plant to withstand the production demand.
With the US Army deal on the horizon, the potential is almost unlimited. Considering this, the true value of the share could be between $5 - 10 dollar within a few years' time frame.

Yesterday and today, I accumulated the share VCIG at the average of .185 waiting for the earnings announcement on the 19th. This stock is way oversold and undervalued.

Cool bro...you are always good at surfing the waves...start calling you The Pacific Kid...LOL

Buying back a few now @.089’s

https://stocktwits.com/Profitier/message/582741515

If there's an update on the appeal turnover, we're likely to see a 1000% straight-up. Let's not forget that they have secured $23 million in new agreements over the past 1.5 months is impressive, but this is just the start. With the US Army deal on the horizon, the potential is almost unlimited. Considering this, the true value of the share could be between $5 - 10 dollar within a few years' time frame.

I'm currently at an average of .0802. This stock is on the verge of a major breakout. It's poised to reach .30+ very soon. We're in pure accumulation mode, gearing up for a significant uptrend. Expect it to be a multi-bagger and a runner over multiple days.

And by recent press releases it is obvious that they are making sales such as this one that made it pop a couple of days ago in pre market....I am anxious to see the quarterly report coming up.
purchase order press release on Aug 13th.
https://ih.advfn.com/stock-market/NASDAQ/akoustis-technologies-AKTS/stock-news/94369401/akoustis-receives-an-additional-purchase-order-for

Yes I believe they started production at the beginning of 2022 according to this article.

Canandaigua manufacturing facility Akoustis Technologies hiring 65, expanding operations
https://www.mpnnow.com/story/business/2021/05/20/akoustis-technologies-expansion-65-new-jobs-canandaigua-ny/5146984001/

Yes sir...I had a friend here a while back alert me on this one....I have re-entered for the second time at .0808

Akoustis plans to service the fast-growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 125,000 sq. ft. ISO-9001:2015 registered commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility — tooled for 150 mm diameter wafers for the design, development, fabrication, and packaging of RF filters, MEMS and other semiconductor devices.
Akoustis Technologies, Inc. is headquartered in the Piedmont technology corridor near Charlotte, North Carolina.

Akoustis Technologies is expanding manufacturing operations in Canandaigua manufacturing facility (pictured) Spread out over 57 acres. This will allow the North Carolina-based company to produce a half-billion RF fillers Patented by the company by the end of the calendar year, according to a company official.

$AKTS .08 loading zone. Folks, don’t stress about a potential R/S (reverse split) that’s not happening right now. You have until October 2024 to keep an eye on things. We need to wait until mid or late August for the appeal result related to the QRVO trial, which we hope will be favorable for AKTS. Then, we have the quarterly report due on September 4th. If the results are positive, which they seem likely to be, the stock could rise. Additionally, there’s a significant lack of news regarding new multi-million-dollar orders that could be announced at any moment. So, don’t worry; instead, hold onto your shares with optimism. This situation, though risky, has the potential to be very profitable. In fact, I’m confident that the stock could reach at least $.75 or more before October. Bullish

AKTS

anyone have Pacer court case on today prolly after hours before we find out anything

Buying back a few now @.089’s

https://stocktwits.com/Profitier/message/582741515

going red

In @ .093...let's FLY...$AKTS

Insiders loaded up here at .50 in january

lol.. https://stocktwits.com/Profitier/message/582736735

pump and dump

AKTS..............................https://stockcharts.com/h-sc/ui?s=AKTS&p=W&b=5&g=0&id=p86431144783

Today 08:00AM
Akoustis Receives an Additional Purchase Order for $13 Million XBAW Filters from Existing Tier-1 Customer
(GlobeNewswire)

Jul-09-24 07:00AM
Akoustis Secures $8 Million in Volume XBAW Orders with Tier-1 Customer
(GlobeNewswire)
-6.62%

AKTS .13+ pre market 25m+ volume.. WOWZER!!!

Looking pretty good going into AHs